Inventor · disambiguated record
Martin Donovan
Also filed as: DONOVAN MARTIN · DONOVAN MARTIN J
24 granted patents·16 pending applications·167 citations·filing 2007–2025
95Inventor score
Top patents by PatentIndex Score
40 records- 0197US8440231B2Swellable particles for drug deliverySMYTH HUGH D·Filed 2012·Granted May 14, 2013·72 cites·21 claims
- 0293US10912778B2Methods for treatment of pulmonary hypertensionRESPIRA THERAPEUTICS INC·Filed 2017·Granted Feb 9, 2021·10 cites·17 claims
- 0393US9649364B2Methods for producing stable therapeutic formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2016·Granted May 16, 2017·12 cites·16 claims
- 0491US10485850B2Methods for producing stable therapeutic formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2017·Granted Nov 26, 2019·8 cites·12 claims
- 0591US8257685B2Swellable particles for drug deliverySMYTH HUGH D·Filed 2007·Granted Sep 4, 2012·17 cites·18 claims
- 0686US2024207365A1Methods for producing stable therapeutic formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0786US2024342249A1Methods for producing stable therapeutic formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0885US8561609B2Dry powder inhalerDONOVAN MARTIN·Filed 2011·Granted Oct 22, 2013·28 cites·34 claims
- 0983US12364701B2PDE5 inhibitor powder formulations and methods relating theretoRESPIRA THERAPEUTICS INC·Filed 2024·Granted Jul 22, 2025·0 cites·33 claims
- 1083US2024041984A1Methods for producing stable therapeutic formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1182US2025332171A1Pde5 inhibitor powder formulations and methods relating theretoRESPIRA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1279US12263174B2Methods and compositions for treatment of pulmonary hypertension and other lung disordersRESPIRA THERAPEUTICS INC·Filed 2022·Granted Apr 1, 2025·0 cites·19 claims
- 1377US11806314B2PDE5 inhibitor powder formulations and methods relating theretoRESPIRA THERAPEUTICS INC·Filed 2022·Granted Nov 7, 2023·0 cites·37 claims
- 1477US11491161B2Methods and compositions for treatment of pulmonary hypertension and other lung disordersRESPIRA THERAPEUTICS INC·Filed 2021·Granted Nov 8, 2022·0 cites·30 claims
- 1577US10525216B2Powder dispersion methods and devicesRESPIRA THERAPEUTICS INC·Filed 2016·Granted Jan 7, 2020·3 cites·12 claims
- 1676US11590205B2Methods for producing stable therapeutic glucagon formulations in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2016·Granted Feb 28, 2023·1 cites·8 claims
- 1774US8651104B2Bead-containing dry powder inhalerDONOVAN MARTIN J·Filed 2012·Granted Feb 18, 2014·10 cites·18 claims
- 1874US2025108180A1Powder dispersion methods and devicesRESPIRA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1974US2025195531A1Methods and compositions for treatment of pulmonary hypertension and other lung disordersRESPIRA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2073US11911390B2PDE5 inhibitor powder formulations and methods relating theretoRESPIRA THERAPEUTICS INC·Filed 2021·Granted Feb 27, 2024·0 cites·11 claims
- 2173US11491160B2Methods and compositions for treatment of pulmonary hypertension and other lung disordersRESPIRA THERAPEUTICS INC·Filed 2021·Granted Nov 8, 2022·0 cites·20 claims
- 2272US11957736B2Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the sameXERIS PHARMACEUTICALS INC·Filed 2023·Granted Apr 16, 2024·0 cites·24 claims
- 2372US2024316158A1Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the sameXERIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2470US2024148680A1Stable levothyroxine compositions in aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2567US2020215162A1Methods for Producing Stable Therapeutic Formulations in Aprotic Polar SolventsXERIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2666US10463815B2Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agentsRESPIRA THERAPEUTICS INC·Filed 2013·Granted Nov 5, 2019·3 cites·10 claims
- 2765US2023001114A1Powder dispersion methods and devicesRESPIRA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2863US11129940B2Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastesXERIS PHARMACEUTICALS INC·Filed 2015·Granted Sep 28, 2021·1 cites·16 claims
- 2962US11576951B2Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the sameXERIS PHARMACEUTICALS INC·Filed 2020·Granted Feb 14, 2023·0 cites·33 claims
- 3062US2024148678A1Sustained release injectable therapeutic formulations using aprotic polar solventsXERIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3160US10682476B2Powder inhaler, system and methodsRESPIRA THERAPEUTICS INC·Filed 2015·Granted Jun 16, 2020·1 cites·4 claims
- 3259US11471623B2Powder dispersion methods and devicesRESPIRA THERAPEUTICS INC·Filed 2019·Granted Oct 18, 2022·0 cites·20 claims
- 3358US2023085357A1Injectable high concentration pharmaceutical formulations and methods of manufacturing and use thereofXERIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3456US2013323310A1Swellable particles for drug deliverySTC UNM·Filed 2013·Application pending·0 cites
- 3549US10441733B2Powder dispersion devices and methodsRESPIRA THERAPEUTICS INC·Filed 2013·Granted Oct 15, 2019·0 cites·21 claims
- 3649US8715770B2Apparatuses and methods for microparticle dry coating of surfacesSELVAM PARTHIBAN·Filed 2011·Granted May 6, 2014·1 cites·7 claims
- 3745US8962063B2Methods and systems for dosing and coating inhalation powders onto carrier particlesSMYTH HUGH D C·Filed 2010·Granted Feb 24, 2015·0 cites·18 claims
- 3845US2011253140A1Formulations containing large-size carrier particles for dry powder inhalation aerosolsSTC UNM·Filed 2009·Application pending·0 cites
- 3938US2019083578A1Use of low dose glucagonXERIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4033US2017007675A1Stable peptide formulations and methods for preparationXERIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Donovan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →